臨床試驗

Bionic Pancreas in CFRD

NCT：NCT06449677 · ACTIVE_NOT_RECRUITING

NCT IDNCT06449677

狀態ACTIVE_NOT_RECRUITING

開始日期2024-09-24

完成時間2027-05-31

SponsorJaeb Center for Health Research (OTHER)

First posted2024-06-10

Last updated2026-09-18

簡要摘要

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。